Press Releases

Company News
View Summary Acura Pharmaceuticals Announces Third Quarter 2016 Financial Results
Nov 14, 2016
PDF 28.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call on November 15, 2016
Nov 9, 2016
PDF 10.7 KB Add to Briefcase
View Summary KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion(R) Abuse-Deterrent Technology
Oct 18, 2016
PDF 20.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2016 Financial Results
Aug 8, 2016
PDF 27.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Webcast on July 14, 2016 to Discuss Additional Data From Study AP-LTX-400
Jul 11, 2016
PDF 12.0 KB Add to Briefcase
View Summary Acura Pharmaceutical's LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities
Jun 8, 2016
PDF 23.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2016 Financial Results
May 2, 2016
PDF 24.9 KB Add to Briefcase
View Summary Indiana Governor's Bill Signing Ceremony Recognizes the Role of Meth-Resistant Technology in Stemming State Meth Problem
Apr 28, 2016
PDF 15.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives Second U.S. Patent for Novel Limitx(TM) Abuse Deterrent Technology
Apr 26, 2016
PDF 16.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host First Quarter 2016 Financial Results Conference Call on May 3, 2016
Apr 21, 2016
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceutical's Limitx(TM) Technology Successfully Demonstrates Oral Abuse Deterrence
Apr 13, 2016
PDF 23.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces FDA Fast Track Designation for the Development of LTX-04
Apr 12, 2016
PDF 17.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective
Mar 30, 2016
PDF 17.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Acknowledges Inclusion of Meth-Resistant Technology in Indiana Legislation
Mar 14, 2016
PDF 13.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Present at the 28th Annual ROTH Conference
Mar 8, 2016
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016
PDF 29.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host 2015 Financial Results Conference Call on March 1, 2016
Feb 22, 2016
PDF 11.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
Feb 1, 2016
PDF 16.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
Dec 17, 2015
PDF 17.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives 2015 Frost & Sullivan North American Opioid Oral Abuse Deterrence Technology Innovation Award
Nov 10, 2015
PDF 12.6 KB Add to Briefcase
Showing 1-20 of 117 Page: 1 2 3 4 5 6  Next 20
Add to Briefcase = add release to Briefcase